Clinical trial · Observational
Collection of Biological Specimens and Associated Health Information
Collection of Biological Specimens and Associated Health Information for Secondary Research in Future Studies
NCT06369441CI-TRIAL-00076138not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to collect blood samples from a large number of individuals with cancer to create a database for researchers to use in future studies. Researchers may use this database to discover new ways to detect and treat cancer and other diseases. Future studies may use stored blood samples to discover how genes affect health and disease.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Other Disease | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Oncology
- description
- Adults (aged 18 or older) who have an active cancer diagnosis with confirmatory pathology results indicating solid tumor and/or hematologic malignancy.
Primary outcomes (1)
- measure
- Biorepository
- timeFrame
- 10 years
- description
- The objective of this study is to establish a biorepository and database of specimens to enable future research on the role of genetic factors in the biological mechanisms of diseases, including cancer, and treatment outcomes.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Are patients of participating study site clinics/clinical groups * Are adults (aged 18 or older) * Have an active cancer diagnosis with confirmatory pathology results indicating solid tumor and/or hematologic malignancy * Participants may have other active diagnoses with confirmatory clinical results Exclusion Criteria: * Individuals who lack the capacity to provide informed consent * Individuals known to be prisoners at time of biological specimen collection
References
Publications (0)
Data not yet available
No reference posted for this study.